TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22138037

Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy (6 cycles of paclitaxel 70 mg/m(2)/wk [3 weeks on/1 week off])
Number of subjects: 220

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy
Number of subjects: 220
Study: 20297616

Group type: EXPERIMENTAL
Intervention: 100 mg rectal indomethacin
Number of subjects: 200
Study: 17397312

Group type: EXPERIMENTAL
Intervention: Power toothbrush (group P)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Manual toothbrush (group M)
Number of subjects: 70
Study: 15730052

Group type: EXPERIMENTAL
Intervention: Post-dilution hemo-filtrate reinfusion (PDHFR)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Standard hemo-filtrate reinfusion (HFR)
Number of subjects: 6
Study: 12518021

Group type: EXPERIMENTAL
Intervention: MCT formula (40% of fat as MCT)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control formula (without MCT)
Number of subjects: 19
Study: 10911770

Group type: EXPERIMENTAL
Intervention: Homogenized meal (HM)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Solid-liquid meal (SM)
Number of subjects: 8
Study: 8721957

Group type: EXPERIMENTAL
Intervention: Bilaterally antegrade selective digital subtraction angiography (DSA)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Bilaterally antegrade selective DSA
Number of subjects: 25

Group type: COMPARATOR
Intervention: Unselective stationary DSA
Number of subjects: 25
Study: 1858625

Group type: EXPERIMENTAL
Intervention: Heparin pretreatment with treadmill exercise (5000 IU intravenously)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Heparin calcium injections (10,000 IU subcutaneously)
Number of subjects: 14
Study: 6955542

Group type: EXPERIMENTAL
Intervention: Breast cancer screening with mammography and palpation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no screening)
Number of subjects: 0
Study: 31295547

Group type: EXPERIMENTAL
Intervention: Stannum metallicum 30x preparation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Systematic negative water control experiments
Number of subjects: 10
Study: 28276743

Group type: EXPERIMENTAL
Intervention: Social modelling (observing positive treatment effects)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control (no difference reported)
Number of subjects: 59
Study: 25621236

Group type: EXPERIMENTAL
Intervention: Clotrimazole ear drops
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Miconazole cream
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Fluconazole ear drops
Number of subjects: 214
Study: 24315243

Group type: EXPERIMENTAL
Intervention: Pain communication plus virtual pain coach
Number of subjects: 23

Group type: COMPARATOR
Intervention: Pain communication only
Number of subjects: 23
Study: 21596371

Group type: EXPERIMENTAL
Intervention: Behavioral Approach Test (BAT)
Number of subjects: 73
Study: 18761755

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT) training for nurses
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual practice (Control)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 80
Study: 17409389

Group type: EXPERIMENTAL
Intervention: Real‐rTMS + RealVMC
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo‐rTMS + PlaceboVMC
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Real‐rTMS + PlaceboVMC
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Placebo‐rTMS + RealVMC
Number of subjects: 27
Study: 15369420

Group type: EXPERIMENTAL
Intervention: Irbesartan (ARB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Losartan (ARB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of trandolapril (ACE inhibitor) and losartan (ARB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Captopril (ACE inhibitor)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trandolapril (ACE inhibitor)
Number of subjects: 0
Study: 11514487

Group type: EXPERIMENTAL
Intervention: Nurse led shared care programme
Number of subjects: 98

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 98
Study: 9344704

Group type: EXPERIMENTAL
Intervention: Linomide
Number of subjects: 0
Study: 8518380

Group type: EXPERIMENTAL
Intervention: Dobutamine (D) at 4 micrograms/kg/min
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Nitroprusside (N) at 0.25 to 1.0 micrograms/kg/min
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Combination of dobutamine and nitroprusside
Number of subjects: 9

Group type: COMPARATOR
Intervention: None (baseline data)
Number of subjects: 9
Study: 3088751

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition (group 2)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Early postoperative enteral feeding (group 3)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard intravenous fluids (group 1)
Number of subjects: 28
Study: 31653779

Group type: EXPERIMENTAL
Intervention: early‐ACLR
Number of subjects: 121

Group type: COMPARATOR
Intervention: optional‐delayed‐ACLR
Number of subjects: 121
Study: 30400222

Group type: EXPERIMENTAL
Intervention: 200 mL of agraz nectar
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 27481624

Group type: EXPERIMENTAL
Intervention: Complex intervention of post-ICU acute hospital rehabilitation including enhanced physiotherapy, nutritional care, information provision, and case management by dedicated rehabilitation assistants.
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 240
Study: 24971661

Group type: EXPERIMENTAL
Intervention: AMG 745 (3 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22721873

Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg alone
Number of subjects: 56

Group type: COMPARATOR
Intervention: Telmisartan 80 mg with S-amlodipine 5 mg
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: S-amlodipine 5 mg alone
Number of subjects: 56

Group type: COMPARATOR
Intervention: S-amlodipine 5 mg with Telmisartan 80 mg
Number of subjects: 56
Study: 20171425

Group type: EXPERIMENTAL
Intervention: Controlled-release (CR) formulation of simvastatin 40 mg
Number of subjects: 53

Group type: COMPARATOR
Intervention: Immediate-release (IR) formulation of simvastatin 40 mg
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both CR and IR formulations
Number of subjects: 53
Study: 17922858

Group type: EXPERIMENTAL
Intervention: Non-malignant biopsy features (including HGPIN, active inflammation, chronic inflammation, biopsy core length, glandular core length)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Incidence of HGPIN
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Active inflammation
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Chronic inflammation
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Mean core length
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Mean glandular core length
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Mean total biopsy length
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Mean total glandular length
Number of subjects: 121
Study: 17035395

Group type: EXPERIMENTAL
Intervention: Intensive telephone counseling encouraging a plant-based diet
Number of subjects: 2922

Group type: EXPERIMENTAL
Intervention: Dietary pattern change without significant vegetable juice consumption
Number of subjects: 2922

Group type: COMPARATOR
Intervention: Control group (comparison group)
Number of subjects: 2922
Study: 14572817

Group type: EXPERIMENTAL
Intervention: Intravenous purified, pasteurized C1 esterase inhibitor concentrate (Berinert® P) at doses of 500‐1000 IU
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Observational studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-marketing experience since 1985
Number of subjects: 0
Study: 11060814

Group type: EXPERIMENTAL
Intervention: Galanthamine (GAL)
Number of subjects: 0
Study: 8753712

Group type: EXPERIMENTAL
Intervention: Cefazolin 1 gram intravenously administered preoperatively and again 15 minutes before skin incision.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cefazolin clearance preoperatively and intraoperatively.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intraoperative blood loss measurement.
Number of subjects: 18
Study: 1484852

Group type: EXPERIMENTAL
Intervention: PRES method of bidirectional carotid stimulation (excitation vs. inhibition)
Number of subjects: 32
Study: 4049918

Group type: EXPERIMENTAL
Intervention: Insight-oriented psychotherapy
Number of subjects: 51

Group type: COMPARATOR
Intervention: Supportive psychotherapy
Number of subjects: 51
Study: 29268024

Group type: EXPERIMENTAL
Intervention: Anterolateral ligament (ALL) reconstruction
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Modified Lemaire lateral extra-articular tenodesis (LET)
Number of subjects: 10

Group type: COMPARATOR
Intervention: ACL reconstruction alone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Combined ACL reconstruction with either ALL reconstruction or LET
Number of subjects: 10
Study: 27179265

Group type: EXPERIMENTAL
Intervention: Modified Natural Cycle Frozen-Thawed Embryo Transfer (mNC-FET)
Number of subjects: 959

Group type: COMPARATOR
Intervention: Artificial Cycle Frozen-Thawed Embryo Transfer (AC-FET)
Number of subjects: 959
Study: 25764097

Group type: EXPERIMENTAL
Intervention: Ototopical and systemic antibiotics
Number of subjects: 230

Group type: COMPARATOR
Intervention: Initial observation
Number of subjects: 230
Study: 23864511

Group type: EXPERIMENTAL
Intervention: Food store-based environmental intervention
Number of subjects: 276
Study: 20679589

Group type: EXPERIMENTAL
Intervention: Telemedicine-based collaborative care intervention for depression; involved a stepped-care model with a nurse depression care manager, clinical pharmacist, and psychiatrist, using electronic medical records and telephone communication.
Number of subjects: 395
Study: 18029973

Group type: EXPERIMENTAL
Intervention: 2-year disease-free survival (DFS)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: 5-year overall survival (OS)
Number of subjects: 126
Study: 15712767

Group type: EXPERIMENTAL
Intervention: Poi consumption (130 g/meal, three times a day for 4 weeks)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no poi consumption for 4 weeks)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Poi consumption
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study: 12908031

Group type: EXPERIMENTAL
Intervention: Brazilian DTPw/Hib combination
Number of subjects: 108

Group type: COMPARATOR
Intervention: European DTPw/Hib combination
Number of subjects: 108
Study: 10566162

Group type: EXPERIMENTAL
Intervention: Vacurette
Number of subjects: 200

Group type: COMPARATOR
Intervention: Pipelle
Number of subjects: 200
Study: 8684794

Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 1845222

Group type: EXPERIMENTAL
Intervention: Dialectical behavior therapy (DBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study: 6645208

Group type: EXPERIMENTAL
Intervention: Potassium citrate therapy (60 mEq/day)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Sodium citrate therapy
Number of subjects: 5
Study: 31411495

Group type: EXPERIMENTAL
Intervention: Pre-ascent cortisol levels
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Fluid retention during altitude stay
Number of subjects: 22
Study: 28299746

Group type: EXPERIMENTAL
Intervention: Fit Extension (FitEx)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Active Living Every Day (ALED)
Number of subjects: 36
Study: 27132200

Group type: EXPERIMENTAL
Intervention: Combination of mifepristone (200mg oral, 36h before surgery) and misoprostol (400μg oral, 3h before surgery)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Misoprostol (400μg oral, 3h before surgery)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Mifepristone (200mg oral, 36h before surgery)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Combination of mifepristone and misoprostol
Number of subjects: 198

Group type: COMPARATOR
Intervention: Misoprostol
Number of subjects: 198

Group type: COMPARATOR
Intervention: Mifepristone
Number of subjects: 198
Study: 25168098

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) with second-generation drug-eluting stents (DES) in patients with previous CABG
Number of subjects: 1709

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) for graft lesions in CABG patients
Number of subjects: 1709

Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI) of native coronary lesions only
Number of subjects: 1709
Study: 22350110

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (300,000 IU)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 19293693

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure via the Boussignac system immediately after extubation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Supplemental oxygen (standard care group)
Number of subjects: 40
Study: 17719361

Group type: EXPERIMENTAL
Intervention: Dispositional optimism
Number of subjects: 735

Group type: EXPERIMENTAL
Intervention: Risk status (high risk)
Number of subjects: 735
Study: 15535488

Group type: EXPERIMENTAL
Intervention: Metoclopramide 5 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Metoclopramide 2.5 mg
Number of subjects: 100
Study: 11832254

Group type: EXPERIMENTAL
Intervention: Individualised educational behavioural treatment delivered by cardiac nurses in hospital
Number of subjects: 114

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 114
Study: 11408126

Group type: EXPERIMENTAL
Intervention: Hydrogel IOL
Number of subjects: 37

Group type: COMPARATOR
Intervention: Silicone IOL
Number of subjects: 37
Study: 9520115

Group type: EXPERIMENTAL
Intervention: Simvastatin therapy
Number of subjects: 4444

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4444
Study: 8293756

Group type: EXPERIMENTAL
Intervention: Electrophysiologic testing (EPS)
Number of subjects: 486

Group type: COMPARATOR
Intervention: Holter monitoring (HM)
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Sotalol therapy
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Absence of prior antiarrhythmic therapy
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Long-term follow-up of patients discharged on a drug predicted to be effective
Number of subjects: 486
Study: 3720045

Group type: EXPERIMENTAL
Intervention: Nifedipine, Metoprolol, or Isosorbide Dinitrate (therapy period)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Placebo (absence of therapy)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Coronary Angiography (in 76 patients)
Number of subjects: 187
Study: 30345475

Group type: EXPERIMENTAL
Intervention: Xanthan gum-based fluid thickener
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (no xanthan gum-based fluid thickener)
Number of subjects: 22
Study: 27660596

Group type: EXPERIMENTAL
Intervention: Paraspinal transcutaneous electrical nerve stimulation (TENS) applied while walking
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo paraspinal TENS applied while walking
Number of subjects: 0
Study: 24163212

Group type: EXPERIMENTAL
Intervention: O-Cam
Number of subjects: 152

Group type: COMPARATOR
Intervention: Cyberball
Number of subjects: 152

Group type: COMPARATOR
Intervention: Recall
Number of subjects: 152
Study: 22404431

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) 6 mg/kg body mass
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 9
Study: 20515418

Group type: EXPERIMENTAL
Intervention: Abacavir/lamivudine/zidovudine (TZV)
Number of subjects: 207

Group type: COMPARATOR
Intervention: NRTIs/PI (standard ART)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Both TZV and NRTIs/PI
Number of subjects: 207
Study: 18541083

Group type: EXPERIMENTAL
Intervention: Sterilized paper towel cleaning method
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 0.9% saline cleaning method
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Soap cleaning method
Number of subjects: 75
Study: 15976759

Group type: EXPERIMENTAL
Intervention: Modified Thrombelastograph (TEG)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Plateletworks (PWA)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Bland-Altman analysis
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Cohen effect size thresholds
Number of subjects: 43
Study: 12760311

Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy
Number of subjects: 29
Study: 10486670

Group type: EXPERIMENTAL
Intervention: Active treatment with nitrendipine (10-40 mg/day) possibly associated with enalapril (5-20 mg/day) and/or hydrochlorothiazide (12.5-25 mg/day)
Number of subjects: 2438

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2438
Study: 8961036

Group type: EXPERIMENTAL
Intervention: Moclobemide (300-450 mg daily)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20-40 mg daily)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Moclobemide
Number of subjects: 183
Study: 1924565

Group type: EXPERIMENTAL
Intervention: Epinephrine (1:250,000, 1:500,000, or 1:1,000,000)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Saline injection
Number of subjects: 26

Group type: COMPARATOR
Intervention: No injection
Number of subjects: 26
Study: 31963378

Group type: EXPERIMENTAL
Intervention: Established T2DM
Number of subjects: 540

Group type: COMPARATOR
Intervention: Newly diagnosed T2DM
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Established T2DM with severe endothelial dysfunction (FMD < 2%)
Number of subjects: 540

Group type: COMPARATOR
Intervention: Newly diagnosed T2DM with non-severe endothelial dysfunction (FMD ≥ 2%)
Number of subjects: 540
Study: 31075423

Group type: EXPERIMENTAL
Intervention: Intervention group (workshops for GPs and PTs)
Number of subjects: 393

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 393
Study: 27540824

Group type: EXPERIMENTAL
Intervention: Strength exercise program
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Walking exercise program
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned, but implied as no exercise)
Number of subjects: 35
Study: 25670364

Group type: EXPERIMENTAL
Intervention: Recombinant human IL-10 injections (subcutaneous)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 24313693

Group type: EXPERIMENTAL
Intervention: Web‐based acceptance and commitment therapy (ACT)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 76
Study: 23033926

Group type: EXPERIMENTAL
Intervention: α‐Epoetin 40000 IU
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: α‐Epoetin 20000 IU
Number of subjects: 80

Group type: COMPARATOR
Intervention: Isotonic saline (placebo)
Number of subjects: 80
Study: 18752998

Group type: EXPERIMENTAL
Intervention: Cardiac (123)I-MIBG scintigraphy in idiopathic RBD patients with or without OSA
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Delayed H/M cut-off value of 1.97
Number of subjects: 63
Study: 17156226

Group type: EXPERIMENTAL
Intervention: Recombinant activated factor VII
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 14981374

Group type: EXPERIMENTAL
Intervention: Fetal fibronectin
Number of subjects: 97

Group type: COMPARATOR
Intervention: Standard management without fetal fibronectin
Number of subjects: 97
Study: 11679600

Group type: EXPERIMENTAL
Intervention: Fibrin sealant (10 mL sprayed onto the wound before tourniquet deflation and wound closure)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (no fibrin sealant)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Fibrin sealant
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study: 9520606

Group type: EXPERIMENTAL
Intervention: Intimate violence intervention (domestic violence program)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ongoing abuse
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abuse
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Injuries from abuse
Number of subjects: 0
Study: 8083097

Group type: EXPERIMENTAL
Intervention: Accelerated multiple daily fraction radiation (44.40 Gy in 12 fractions, 3.7 Gy BID)
Number of subjects: 290

Group type: COMPARATOR
Intervention: 2-week rest interval
Number of subjects: 290

Group type: COMPARATOR
Intervention: 4-week rest interval
Number of subjects: 290
Study: 2577482

Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg nocte for 4 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg nocte for 4 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cimetidine 1600 mg nocte for 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 334210

Group type: EXPERIMENTAL
Intervention: Buprenorphine 2 microgram/kg
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Buprenorphine 8 microgram/kg
Number of subjects: 172

Group type: COMPARATOR
Intervention: Pethidine 1 mg/kg
Number of subjects: 172

Group type: COMPARATOR
Intervention: Pentazocine 0.6 mg/kg
Number of subjects: 172
Study: 31744527

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 29044008

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting balloon
Number of subjects: 120

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents
Number of subjects: 120
Study: 25765965

Group type: EXPERIMENTAL
Intervention: Slow growth BCG batches
Number of subjects: 1633
Study: 22630616

Group type: EXPERIMENTAL
Intervention: Modafinil (200 mg for the first 5 days and 100 mg on days 6 and 7)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 22093474

Group type: EXPERIMENTAL
Intervention: DTaP-IPV//PRP-T combined vaccine (PENTAXIM(TM)) vaccinated at 2, 3, 4 months of age
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DTaP-IPV//PRP-T combined vaccine (PENTAXIM(TM)) vaccinated at 3, 4, 5 months of age
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group: DTaP, Hib tetanus conjugate (Act-HIB(TM)), and IPV (IMOVAX PolioTM(TM)) vaccines vaccinated at 3, 4, 5 months of age
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DTaP-IPV//PRP-T combined vaccine
Number of subjects: 0
Study: 19451321

Group type: EXPERIMENTAL
Intervention: 1% tenofovir gel
Number of subjects: 36

Group type: COMPARATOR
Intervention: K‐Y Jelly
Number of subjects: 36